FHLC:ARCA-Fidelity MSCI Health Care Index

ETF | Health | NYSE Arca

Last Closing Price

USD 42.09

Change

+0.09 (+0.21)%

Market Cap

USD 0.97B

Volume

0.39M

Yahoo Analyst Target

N/A

STA Analyst Target

N/A
Yahoo Analyst Rating

N/A

STA Analyst Rating

N/A

STA Verdict

Verdict

About

The investment seeks to provide investment returns that closely correspond to the price and yield performance of the Nasdaq Composite Index?. The fund normally invests at least 80% of assets in common stocks included in the index. It uses statistical sampling techniques that take into account such factors as capitalization, industry exposures, dividend yield, price/earnings (P/E) ratio, price/book (P/B) ratio, and earnings growth to create a portfolio of securities listed in the Nasdaq Composite Index that have a similar investment profile to the entire index.

Inception Date: 21/10/2013

Primary Benchmark: MSCI USA IMI/Health Care NR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.12%

Management Expense Ratio: 0.08 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2018-01-16 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV SPDR Select Sector Fund - Heal.. 0.14 %

+0.43 (+0.50%)

USD 17.56B
VHT Vanguard Health Care 0.10 %

+0.25 (+0.15%)

USD 7.51B
XBI SPDR Series Trust S&P Biotech 0.35 %

-2.78 (-3.10%)

USD 4.61B
IYH iShares U.S. Healthcare 0.44 %

+0.62 (+0.34%)

USD 2.04B
IXJ iShares Global Healthcare 0.48 %

+0.06 (+0.05%)

USD 1.70B
IHI iShares U.S. Medical Devices 0.44 %

-0.58 (-0.32%)

USD 1.58B
FBT First Trust Amex Biotech Index.. 0.56 %

-2.94 (-2.22%)

USD 1.28B
FXH First Trust Health Care AlphaD.. 0.62 %

-0.34 (-0.46%)

USD 1.04B
HQH Tekla Healthcare Investors 0.00 %

-0.10 (-0.42%)

USD 0.97B
THQ Tekla Healthcare Opportunies F.. 0.00 %

-0.03 (-0.17%)

USD 0.78B

ETFs Containing FHLC

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health)
Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.25% 75% C 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.25% 75% C 78% C+
Trailing 12 Months  
Capital Gain 23.65% 64% D 76% C
Dividend Return 1.62% 65% D 22% F
Total Return 25.27% 68% D+ 74% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.34% 43% F 69% D+
Dividend Return 9.66% 32% F 64% D
Total Return 1.32% 61% D- 24% F
Risk Return Profile  
Volatility (Standard Deviation) 12.30% 75% C 60% D-
Risk Adjusted Return 78.52% 57% F 67% D+
Market Capitalization 0.58B 68% D+ 53% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.